Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series

Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).

Detalles Bibliográficos
Autores principales: Dogan, Lerzan, Kaya, Dilaver, Sarikaya, Tugce, Zengin, Rehile, Dincer, Alp, Akinci, Ibrahim Ozkan, Afsar, Nazire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204750/
https://www.ncbi.nlm.nih.gov/pubmed/32389697
http://dx.doi.org/10.1016/j.bbi.2020.05.022
_version_ 1783530112154599424
author Dogan, Lerzan
Kaya, Dilaver
Sarikaya, Tugce
Zengin, Rehile
Dincer, Alp
Akinci, Ibrahim Ozkan
Afsar, Nazire
author_facet Dogan, Lerzan
Kaya, Dilaver
Sarikaya, Tugce
Zengin, Rehile
Dincer, Alp
Akinci, Ibrahim Ozkan
Afsar, Nazire
author_sort Dogan, Lerzan
collection PubMed
description Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).
format Online
Article
Text
id pubmed-7204750
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-72047502020-05-07 Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series Dogan, Lerzan Kaya, Dilaver Sarikaya, Tugce Zengin, Rehile Dincer, Alp Akinci, Ibrahim Ozkan Afsar, Nazire Brain Behav Immun Article Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU). Elsevier Inc. 2020-07 2020-05-07 /pmc/articles/PMC7204750/ /pubmed/32389697 http://dx.doi.org/10.1016/j.bbi.2020.05.022 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Dogan, Lerzan
Kaya, Dilaver
Sarikaya, Tugce
Zengin, Rehile
Dincer, Alp
Akinci, Ibrahim Ozkan
Afsar, Nazire
Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series
title Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series
title_full Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series
title_fullStr Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series
title_full_unstemmed Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series
title_short Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series
title_sort plasmapheresis treatment in covid-19–related autoimmune meningoencephalitis: case series
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204750/
https://www.ncbi.nlm.nih.gov/pubmed/32389697
http://dx.doi.org/10.1016/j.bbi.2020.05.022
work_keys_str_mv AT doganlerzan plasmapheresistreatmentincovid19relatedautoimmunemeningoencephalitiscaseseries
AT kayadilaver plasmapheresistreatmentincovid19relatedautoimmunemeningoencephalitiscaseseries
AT sarikayatugce plasmapheresistreatmentincovid19relatedautoimmunemeningoencephalitiscaseseries
AT zenginrehile plasmapheresistreatmentincovid19relatedautoimmunemeningoencephalitiscaseseries
AT dinceralp plasmapheresistreatmentincovid19relatedautoimmunemeningoencephalitiscaseseries
AT akinciibrahimozkan plasmapheresistreatmentincovid19relatedautoimmunemeningoencephalitiscaseseries
AT afsarnazire plasmapheresistreatmentincovid19relatedautoimmunemeningoencephalitiscaseseries

Ejemplares similares